| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥23.32 |
| 52 Week High | CN¥54.80 |
| 52 Week Low | CN¥17.01 |
| Beta | 0 |
| 1 Month Change | -10.41% |
| 3 Month Change | -21.56% |
| 1 Year Change | -19.75% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -50.32% |
Recent News & Updates
Shareholder Returns
| 301234 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 6.5% | 6.4% | 2.1% |
| 1Y | -19.8% | -16.8% | -14.2% |
Return vs Industry: 301234 underperformed the CN Medical Equipment industry which returned -18.6% over the past year.
Return vs Market: 301234 underperformed the CN Market which returned -14.6% over the past year.
Price Volatility
| 301234 volatility | |
|---|---|
| 301234 Average Weekly Movement | 11.9% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 301234's share price has been volatile over the past 3 months.
Volatility Over Time: 301234's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 892 | Hongyu Zhang | www.hongyu-wuzhou.com |
Anhui Hongyu Wuzhou Medical Manufacturer Co.,Ltd. engages in the research, development, production, and sale of disposable sterile medical instruments in China. It offers disposable syringes, infusion (blood) devices, puncture needles, hypodermic needles, blood collection needles and sets, conventional syringes, and insulin syringes and pen needles, as well as infusion, blood administration, burette, and scalp vein sets.
Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. Fundamentals Summary
| 301234 fundamental statistics | |
|---|---|
| Market cap | CN¥1.59b |
| Earnings (TTM) | CN¥57.18m |
| Revenue (TTM) | CN¥506.36m |
27.7x
P/E Ratio3.1x
P/S RatioIs 301234 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301234 income statement (TTM) | |
|---|---|
| Revenue | CN¥506.36m |
| Cost of Revenue | CN¥404.78m |
| Gross Profit | CN¥101.59m |
| Other Expenses | CN¥44.40m |
| Earnings | CN¥57.18m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 20.06% |
| Net Profit Margin | 11.29% |
| Debt/Equity Ratio | 0% |
How did 301234 perform over the long term?
See historical performance and comparison